Form 4: Exozymes VP of Research Boosts Stake with Significant Stock Purchase

Tyler Paz Korman, Vice President of Research at Exozymes Inc., acquired 2,990 shares of common stock at $12.54 per share, increasing his beneficial ownership to 725,291 shares.

Summary

• Tyler Paz Korman, the Vice President of Research at EXOZYMES INC. (EXOZ), reported an acquisition of company common stock.
• The transaction involved the purchase of 2,990 shares of common stock.
• The shares were acquired at a price of $12.54 per share.
• Following this transaction, Mr. Korman's total beneficial ownership in Exozymes Inc. stands at 725,291 shares.
• The transaction date for this acquisition was June 16, 2025.

Sentiment

Score: 8

Explanation: The acquisition of shares by a key insider, the Vice President of Research, signals strong confidence in the company's prospects and valuation.

Positives

• Tyler Paz Korman, a key executive as Vice President of Research, increased his direct ownership in Exozymes Inc. by acquiring 2,990 shares.
• The acquisition of shares by an insider at a price of $12.54 per share indicates confidence in the company's future prospects and valuation.
• The transaction increases Mr. Korman's total beneficial ownership to 725,291 shares, further aligning his interests with shareholders.

Future Outlook

NA

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• Acquisition of 2,990 shares of common stock by Tyler Paz Korman, Vice President, Research, from the issuer.

Stakeholder Impact

• Shareholders: The insider purchase may be interpreted as a positive signal, potentially increasing investor confidence.

Key Dates

Recommendation

Keywords

Exozymes, EXOZ, insider trading, stock purchase, Form 4, beneficial ownership, Tyler Korman, officer transaction